B+
Bull case
25%
Probability
Target price
$4.30
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
KRMD
KORU MedicalCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Sustained domestic infusion-device demand, delivery of 2026 guidance and eventual connected-monitoring adoption could support a higher valuation. Q2 growth and margin improvement provide operating evidence, but the technology contribution remains unproven [#SEC-8K-2026-08-05].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
International growth may moderate as specific European markets convert to pre-filled syringes [#SEC-8K-2026-08-05].
Momentum
96
Value
42
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.35 · Bull $4.30 · Bear $2.15Analysis 2026-09-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $6.25
Why
Momentum96 · Δ7d -
Value42 · Δ7d +0.0
Sentiment53 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • International growth may moderate as specific European markets convert to pre-filled syringes [#SEC-8K-2026-08-05].
- • Positive adjusted EBITDA and year-end cash above $7.5 million remain guidance targets, not achieved full-year results [#SEC-8K-2026-08-05].
- • European conversion timing could slow international growth, while the withdrawn Phesgo application delays the prior U.S.
Catalyst clock
2026-12-31
Delivery against refined 2026 guidance
Lead driver: Sentiment · See AI snapshot
Momentum
96
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
42
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
53
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 96.0 / Value 41.7 / Sentiment 52.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-29. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$3.35
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.15
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$146.37M
Beta
0.44
Shares Out
46.17M
P/E (TTM) · Derived
-55.5
P/S (TTM)
6.60
P/FCF (TTM) · Derived
190.96
Rev YoY
+18.2%
EPS YoY
-213.3%
Gross Margin
+60.7%
Op Margin
-3.7%
Net Debt
-$5.38M
Current Ratio
2.72
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data